(Q46255351)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18997733%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

title

Evaluation of EGFR abnormalities in patients with pulmonary adenocarcinoma: the need to test neoplasms with more than one method (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18997733%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18997733%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Aditi M Dastane

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18997733%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Farahnaz Forozan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18997733%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Amin Riley-Portuguez

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18997733%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Fai Chung

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18997733%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Jean Lopategui

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18997733%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Alberto M Marchevsky

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18997733%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

publication date

7 November 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18997733%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18997733%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18997733%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18997733%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

128-133

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18997733%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/modpathol.2008.182

26 December 2019

exact match

0 references

cites work

Confidence and uncertainty long after initial treatment for early prostate cancer: survivors' views of cancer control and the treatment decisions they made.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.182

21 January 2018

Cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.182

7 January 2021

Biomarkers for prediction of sensitivity to EGFR inhibitors in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.182

7 January 2021

Epidermal growth factor receptor gene amplification and gefitinib sensitivity in patients with recurrent lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.182

7 January 2021

Mutation in the tyrosine kinase domain of epidermal growth factor receptor is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.182

7 January 2021

Prediction of sensitivity of advanced non-small cell lung cancers to gefitinib (Iressa, ZD1839).

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.182

7 January 2021

Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.182

7 January 2021

Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.182

7 January 2021

Analysis of epidermal growth factor receptor expression as a predictive factor for response to gefitinib ('Iressa', ZD1839) in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.182

7 January 2021

Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrence

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.182

7 January 2021

Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.182

7 January 2021

Epidermal growth factor receptor mutations and gene amplification in non-small-cell lung cancer: molecular analysis of the IDEAL/INTACT gefitinib trials

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.182

7 January 2021

EGFR mutations in lung adenocarcinomas: clinical testing experience and relationship to EGFR gene copy number and immunohistochemical expression

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.182

7 January 2021

Increased epidermal growth factor receptor gene copy number detected by fluorescence in situ hybridization associates with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma subtypes: a Southwest Oncology Group Study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.182

7 January 2021

Comparative analysis of epidermal growth factor receptor mutations and gene amplification as predictors of gefitinib efficacy in Japanese patients with nonsmall cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.182

7 January 2021

Erlotinib in lung cancer - molecular and clinical predictors of outcome

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.182

7 January 2021